AssetMark Inc
RVMD icon

AssetMark Inc’s Revolution Medicines RVMD Stock Holding History

AssetMark Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
6,589
+6,404
+3,462% +$935K ﹤0.01% 1051
2026
Q1 		$18K Buy
185
+53
+40% +$5.35K ﹤0.01% 2092
2025
Q4 		$10.5K Buy
132
+39
+42% +$2.56K ﹤0.01% 2200
2025
Q3 		$4.34K Sell
93
-5
-5% -$196 ﹤0.01% 2393
2025
Q2 		$3.6K Buy
98
+86
+717% +$3.3K ﹤0.01% 2241
2025
Q1 		$424 Hold
12
– – ﹤0.01% 2448
2024
Q4 		$525 Buy
12
+10
+500% +$505 ﹤0.01% 2365
2024
Q3 		$91 Buy
+2
New +$87 ﹤0.01% 2206
2024
Q1 		– Sell
-6
Closed -$172 – 2089
2023
Q4 		$172 Buy
+6
New +$144 ﹤0.01% 1783

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

AssetMark Inc's RVMD Position: Q2 2026 in Review

AssetMark Inc increased its Revolution Medicines (RVMD) stake by 3,462% in Q2 2026, buying an estimated $935K and bringing the position to 6,589 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

AssetMark Inc first reported a position in RVMD in Q4 2023 and has held it in 9 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • AssetMark Inc held 6,589 shares of Revolution Medicines worth $1.23M as of Q2 2026.
  • AssetMark Inc bought 6,404 Revolution Medicines shares in Q2 2026, an estimated $935K.
  • Revolution Medicines made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1051 holding.
  • AssetMark Inc first reported a position in Revolution Medicines in Q4 2023 and has held it in 9 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.